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Inoue BH, dos Santos L, Pessoa TD, Antonio EL, Pacheco
BPM, Savignano FA, Carraro-Lacroix LR, Tucci PJF, Malnic G,
Girardi ACC. Increased NHE3 abundance and transport activity in
renal proximal tubule of rats with heart failure. Am J Physiol Regul
Integr Comp Physiol 302: R166–R174, 2012. First published October
26, 2011; doi:10.1152/ajpregu.00127.2011.—Heart failure (HF) is
associated with a reduced effective circulating volume that drives
sodium and water retention and extracellular volume expansion. We
therefore hypothesized that Na/H exchanger isoform 3 (NHE3),
the major apical transcellular pathway for sodium reabsorption in the
proximal tubule, is upregulated in an experimental model of HF. HF
was induced in male rats by left ventricle radiofrequency ablation.
Sham-operated rats (sham) were used as controls. At 6 wk after
surgery, HF rats exhibited cardiac dysfunction with a dramatic in-
crease in left ventricular end-diastolic pressure. By means of station-
ary in vivo microperfusion and pH-dependent sodium uptake, we
demonstrated that NHE3 transport activity was significantly higher in
the proximal tubule of HF compared with sham rats. Increased NHE3
activity was paralleled by increased renal cortical NHE3 expression at
both protein and mRNA levels. In addition, the baseline PKA-
dependent NHE3 phosphorylation at serine 552 was reduced in renal
cortical membranes of rats with HF. Collectively, these results suggest
that NHE3 is upregulated in the proximal tubule of HF rats by
transcriptional, translational, and posttranslational mechanisms. En-
hanced NHE3-mediated sodium reabsorption in the proximal tubule
may contribute to extracellular volume expansion and edema, the
hallmark feature of HF. Moreover, our study emphasizes the impor-
tance of undertaking a cardiorenal approach to contain progression of
cardiac disease.
myocardial injury; renal function; volume homeostasis; radiofre-
quency ablation.
HEART FAILURE (HF) is a multifaceted clinical syndrome char-
acterized by reduced cardiac output and/or diastolic dysfunc-
tion associated with venous and capillary congestion. These
initial alterations in cardiac function are accompanied by a
progressive series of systemic abnormalities at both functional
and structural levels. A number of physiological mechanisms
are triggered in the face of impaired cardiovascular hemody-
namics and sustained loss of myocardial contractility caused by
heart disease. Many of these mechanisms are adaptive on a
short-term basis but are often maladaptive over the long term.
Underfilling of the arterial system, a major hemodynamic
abnormality in HF evokes a number of neurohumoral re-
sponses to maintain sufficient blood flow delivery to peripheral
organs and thereby compensate for the progressively declining
cardiac performance (7, 8). Stimulation of these neurohumoral
mechanisms, which include activation of the sympathetic and
renin-angiotensin-aldosterone systems (RAAS) and enhanced
vasopressin release, may, in fact, further aggravate HF through
increased cardiac load and excessive sodium and water reten-
tion by the kidneys (16, 17, 21, 38, 39).
The apical entry of sodium constitutes the rate-limiting step
in transepithelial sodium and fluid transport. Hence, any
changes in either the number and/or the intrinsic activity of the
proteins mediating this entry can affect the rate of renal tubular
reabsorption (30). Recent studies provide compelling evidence
that increased protein abundance of the predominant apical
sodium transporters may play an important role in the patho-
genesis of sodium and water retention in HF. It has been
demonstrated by several investigators that the protein abun-
dance of the Na-K-2Cl cotransporter NKCC2 is increased
in the thick ascending limb of rats with HF induced by ligation
of the left anterior descending coronary artery (LAD) (28, 31,
43, 48). Most recently, Lütken et al. (28) have shown that
LAD-induced HF is associated with increased protein expres-
sion of Na/H exchanger isoform 3 (NHE3) in renal cortex
and outer medulla and altered expression of the epithelial
sodium channel (ENaC) subunits. Nonetheless, to the best of
our knowledge, there are no reports to date that have directly
demonstrated that the activity of any of the major apical
sodium transport proteins within the nephron is increased
in HF.
The proximal tubule reabsorbs approximately two-thirds of
the filtered sodium. NHE3-mediated Na/H exchange is the
principal apical membrane mechanism for sodium reabsorption
in this nephron segment (4, 40, 51, 52). Considering the
quantitative importance of NHE3 in mediating sodium reab-
sorption in the renal proximal tubule, changes in the activity of
this exchanger for extended periods can have a great impact on
extracellular volume homeostasis. We therefore hypothesized
that NHE3 activity is increased in the renal proximal tubule of
HF rats, potentially contributing to sodium retention, extracel-
lular volume expansion, and ultimately to edema. In the present
study, we made use of both in vivo and ex vivo approaches to
measure NHE3 activity in an experimental model of HF,
recently developed by Antonio et al. (2) in which rats are
subjected to myocardial injury by means of radiofrequency
ablation of the left ventricle. The molecular mechanisms un-
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derlying altered regulation of NHE3 in the renal proximal
tubule of rats with HF were also explored.
MATERIALS AND METHODS
Animal protocols and surgical procedures. All animal work was
conducted in accordance with the ethical principles in animal research
of the Brazilian College of Animal Experimentation and was ap-
proved by the institutional animal care and use committee. Experi-
mental HF was induced in male Wistar rats (200–250 g) by left
ventricular (LV) myocardial injury after radiofrequency catheter ab-
lation (2). In brief, rats were anesthetized with halothane and a left
thoracotomy was performed at the fourth intercostal space. The left
pericardium was opened, and the tip of a custom-made catheter was
placed on the LV anterolateral wall, perpendicular to the tissue, under
constant manual pressure. LV lesions were created by delivering
high-frequency currents (1,000 KHz, 12 watts, during 10 s) generated
by a conventional radiofrequency generator (model TEB RF10; Tec-
nologia Eletrônica Brasileira, São Paulo, Brazil). The damaged area
was immediately visualized by the presence of a clear, white disk-
shaped region of coagulation necrosis. Thereafter, the heart was
quickly returned to the thorax, and a suture was used to close the
chest. Sham-operated rats underwent left thoracotomy and were
mockingly ablated. All the following experimental procedures were
performed 6 wk after myocardial injury for HF induction or sham
operation.
Renal function studies. Rats were anesthetized with ketamine-
xylazine-acepromazine (64.9, 3.20, and 0.78 mg/kg sc, respectively)
and placed on a heated surgical table to maintain body temperature.
After tracheostomy, polyethylene (PE) catheters were inserted into the
jugular vein and the urinary bladder for inulin infusion and urine
collection, respectively. To control mean arterial pressure (MAP) and
allow blood sampling, a PE-60 catheter was inserted into the right
carotid artery. Glomerular filtration rate was determined by measuring
the clearance of inulin as follows. First, a loading dose of inulin (100
mg/kg in 0.9% saline) was administered and, subsequently, continu-
ous infusions of inulin (10 mg/kg in 0.9% saline) were made at 0.04
ml/min. Three consecutive 30-min periods of urine collection were
performed. Blood samples were obtained at the beginning and at the
end of the experiment. Plasma and urine sodium concentrations were
measured by flame photometry (model B262; Micronal, São Paulo,
Brazil), and inulin was determined by using the anthrone method (12).
Hemodynamic studies. After renal function assessment, invasive
hemodynamic studies were performed to evaluate cardiac perfor-
mance. Rats were anesthetized using an intraperitoneal injection of
ketamine (50 mg/kg) and xylazine (10 mg/kg) and placed on a heated
rodent operating table (37°C) under oxygen-enriched mechanical
ventilation. A MicroTip pressure-volume catheter (model 1.4 French
SPR 839; Millar Instruments, Houston, TX) was then inserted into the
right carotid artery and positioned immediately above the aortic
valves to monitor aortic blood pressure. After 5 min of arterial blood
pressure recording, the catheter was advanced into the LV cavity for
simultaneous and continuous pressure and volume measurements.
Volume calibration was accomplished by using a linear volume-
conductance regression of the absolute blood volume (4 cylindrical
chambers containing a specified volume of fresh heparinized rat
blood) versus the correspondent signal acquired by the conductance
catheter. Data were acquired for computer analysis (PVAN Software,
Millar Instruments) using LabChart 7 Software System (PowerLab,
ADInstruments, Bella Vista, NSW, Australia). The following data
were obtained: heart rate (HR), MAP, LV end-systolic and end-
diastolic pressures (LVEDP), maximal rate of LV pressure rise (dP/
dtmax) and decline (dP/dtmax), time constant of LV pressure decay
(Tau), stroke volume, cardiac output, and stroke work. Tau was
calculated as the time constant of monoexponential pressure decay
during the isovolumetric relaxation: P(t)  A  B exp(t/Tau). The
total peripheral resistance index (TPRI) was calculated (TPRI 
MAP/cardiac output). Only rats with LVEDP  15 mmHg were in-
cluded in the HF group.
Stationary in vivo microperfusion. Experiments were carried out
essentially as described previously (10), including anesthesia and
surgical preparation for in vivo micropuncture. Proximal tubules were
punctured by means of a double-barreled micropipette, one barrel
being used to inject FDC green-colored Ringer perfusion solution and
the other to inject Sudan-black colored castor oil. To measure luminal
pH, proximal tubules were impaled by a double-barreled asymmetric
microelectrode, the larger barrel containing the H-ion sensitive
ion-exchange resin and the smaller barrel containing the reference
solution (1 M KCl) colored by FDC green. By continuously measur-
ing the luminal pH toward the steady-state level, the rate of tubular
acidification, representing bicarbonate reabsorption, was evaluated in
a solution, isolated, and blocked by oil. Thereby, luminal HCO3
activity, starting at 25 mM (perfusion solution) was progressively
reduced to a stationary level by H secretion. The voltage between the
microelectrode barrels, representing luminal H activity, was contin-
uously recorded by means of a microcomputer equipped with an AD
converter (Lynx, São Paulo, Brazil). Luminal bicarbonate was calcu-
lated from luminal pH and arterial blood PCO2, and the rate of tubular
acidification was expressed as the half time of the exponential reduc-
tion of the injected HCO3 concentration to its stationary level.
Postmortem analysis. At the end of the experimental procedures,
rats were killed by decapitation, and their hearts, lungs, and kidneys
were quickly removed. Heart injury in HF rats was evaluated as
follows. Right and left ventricle, including the interventricular septum
were separately weighed, fixed in 10% formalin, and embedded in
paraffin. Sections (5 m) of paraffin-embedded tissue were mounted
onto slides and stained with Picrossirius red for measurement of
collagen scar and LV cavity perimeter. The slides were next scanned
and digitally analyzed (Image Tool 3.0; University of Texas Health
Science Center San Antonio, San Antonio, TX). Myocardial lesion
was quantified by the percentage of LV perimeter containing scar
tissue. Lung weights (indexed by body weight and tibia length) were
taken as a marker of pulmonary congestion. Kidney cortices were cut
off and used for the preparation of either renal cortical membrane
vesicles or for RNA isolation.
Isolation of renal cortical membranes. Renal cortical membranes
were prepared by differential centrifugation of renal cortical homog-
enates from individual animals as described previously (11). Protein
concentration was determined by the method of Lowry (27).
Microvillus membrane preparation. Microvillus membrane vesi-
cles (MMV) were isolated from renal cortices of individual animals as
described previously (3). Membranes were isolated and stored in 200
mM mannitol, 80 mM HEPES, 41 mM KOH, 1 M pepstatin, 1 M
leupeptin, 230 M PMSF, pH 7.5 at 80°C. MMV preparations used
in this study were 11- to 14-fold enriched in specific activity of the
brush-border membrane marker enzyme -glutamyltranspeptidase rel-
ative to kidney homogenates. Protein concentration was determined
by the method of Lowry (27).
Radioactive sodium uptake. Renal cortical membranes were
washed and equilibrated for 2 h at room temperature in 254 mM
mannitol, 35 mM KOH, 68 mM HEPES, 50 mM MES, pH 6.0. The
membranes were then centrifuged and resuspended in the same
solution at a final protein concentration of 10 g/l. The uptake of
22Na was then assayed after mixing 10 l of the renal cortical
membrane suspension with 90 l of a hot solution containing 0.1 Ci
of 22Na, 300 mM mannitol, 42 mM KOH, 80 mM HEPES, pH 7.5.
The uptake reaction was stopped after 10 s by the addition of 3 ml
ice-cold solution (stop solution) containing 100 mM KCl, 42 mM
KOH, 80 mM HEPES, pH 7.5. Renal cortical membrane vesicles were
collected on 0.65-m Millipore filters. After the filters were washed
with an additional 9.0 ml of stop solution, 22Na radioactivity was
measured using a liquid scintillation counter. Some experiments were
performed in the presence of 10 M (S3226) to inhibit NHE3 activity.
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SDS-PAGE and immunoblotting. Protein samples were subjected to
SDS-PAGE, transferred to polyvinylidene fluoride (PVDF) mem-
branes (Immobilon-P; Millipore, Bedford, MA) and prepared for
immunoblotting as previously described (10). The PVDF membranes
were incubated with Blotto (5% nonfat dry milk and 0.1% Tween 20
in PBS, pH 7.4) for 1 h at room temperature to block nonspecific
binding and were subsequently incubated overnight at 4°C with the
primary antibody in Blotto at the following concentrations: 1:1,000
anti-PS552 (24), 1:1,000 anti-NHE3 (5), or 1:50,000 anti-actin. The
membranes were then washed five times with Blotto and incubated for
1 h with horseradish peroxidase-conjugated immunoglobulin second-
ary antibody (1:2,000). Membranes were again washed five times with
Blotto and then rinsed in PBS. Bound antibody was detected using an
enhanced chemiluminescence system (GE Healthcare) according to
the manufacturer’s protocols. The visualized bands were digitized
using the ImageScanner III (GE HealthCare) and quantified using
Image Software (Scion, Federick, MD).
RNA isolation and real-time RT-PCR reaction. Total RNA was
isolated by the acid guanidinium thiocyanate phenol-chloroform
method and cDNA synthesis was performed with random hexamers
(High Capacity cDNA Archive kit-PE; Applied Biosystems) follow-
ing the manufacturer’s guidelines. Fifteen nanograms of cDNA were
used for real-time RT-PCR reaction (SYBR Green PCR Master
Mix-PE; Applied Biosystems) in an ABI Prism 7700 Sequence
Detection System (Applied Biosystems). All samples were assayed in
triplicate. The comparative threshold cycle method was used for data
analyses. The following oligonucleotide primers were used: NHE3:
5=-ACTGCTTAATGACGCGGTGACTGT-3= (forward) and 5=-
AAAGACGAAGCCAGGCTCGATGAT-3= (reverse), and 28S: 5=-
TCATCAGACCCCAGAAAAGG-3= (forward) and 5=-GATTCG-
GCAGGTGAGTTG-3= (reverse).
Statistical analyses. All results are reported as means  SE with n
indicating the number of observations. Comparisons between two
groups were performed using unpaired t-tests. If more than two groups
were compared, statistical significance was determined by ANOVA
followed by Tukey’s post hoc test. Results were considered significant
when P  0.05.
RESULTS
Experimental model, biometric, and cardiac parameters.
Herein, we used an experimental model of HF in which rats
were subjected to myocardial injury by means of LV radiofre-
quency ablation (2). The major advantages of this model are
the very consistent size of myocardial injury and low imme-
diate (24 h) mortality rate. Accordingly, only 1 out of 22 rats
died 24 h after being subjected to the procedure. Additionally,
6 wk after LV radioablation, we verified by standard histolog-
ical analysis with Picrossirius red staining that LV radiofre-
quency ablation gave rise to a myocardial injury that was very
reproducible in terms of both site (Fig. 1) and size (35.4 
2.6% of LV).
Table 1 summarizes the biometric parameters found in HF
and sham-operated rats. Compared with sham animals, rats
with HF did not display significant changes in body or absolute
heart weight. However, when normalized by tibial length or
body wt, relative heart weight was significantly increased in
HF animals. In addition, the relative weight of the wet right
lung was also significantly increased in HF animals compared
with the sham group, suggestive of pulmonary congestion
secondary to cardiac decompensation.
Figure 2 shows representative steady-state pressure-volume
loops (P-V loops; Fig. 2A) and the pressure signal and dP/dt
(Fig. 2B) obtained from individual HF and sham rats 6 wk after
LV radioablation or sham operation, illustrating the typical
hemodynamic changes that occur in HF. The rightward shift of
the P-V loops and the decrease of the area within the P-V loop
curves and of dP/dt in HF rats indicates a decrease in cardiac
performance. As shown in Table 2, HF was associated with a
significant decrease of the maximal slope of the systolic pres-
sure increment (dP/dtmax), cardiac output, and stroke work
when compared with sham animals, with no significant
changes in HR, LV systolic pressure, and MAP, overall sug-
gestive of relative LV systolic impairment. Furthermore, max-
imal rate of LV pressure decline (dP/dtmax) was depressed
(Fig. 2B and Table 2) and LVEDP (Fig. 2B and Table 2) and
the time constant of isovolumetric relaxation (Tau) (Table 2)
were increased in HF animals, indicating diastolic dysfunction.
The TPRI was also significantly increased in HF rats. In line
with previous findings (2), our data indicate that this experi-
mental model of post-myocardial injury HF displays many
abnormalities of cardiac function that resembles the human
syndrome.
Renal function evaluation. Renal function studies were car-
ried out 6 wk after myocardial injury or sham operation. As
shown in Table 3, urinary flow, glomerular filtration rate,
urinary excretion of sodium, and fractional excretion of sodium
were not statistically different between HF and sham, although
a tendency to a decrease in rats with HF was observed. Daily
sodium and water intake were also measured in sham and HF
Fig. 1. Representative hearts of sham-operated and rats that underwent left ventricle (LV) radiofrequency ablation [heart failure (HF)]. Sections (5 m) of
paraffin-embedded cardiac tissue were mounted onto slides and stained with Picrossirius red for measurement of collagen scar and LV cavity perimeter.
Table 1. Organ weights for sham-operated and heart failure
rats
Sham Heart Failure
No. 7 9
Body weight, g 441  12 446  17
Tibia length, mm 40.4  0.4 40.7  0.5
Heart wt, mg 1,230  39 1,336  33
Heart wt/body wt, mg/g 2.79  0.03 3.03  0.06*
Heart wt/tibia, mg/mm 29.6  1.2 33.6  0.5*
Right lung, mg 1,170  71 1,428  128
Right lung/body wt, mg/g 2.55  0.13 4.11  0.49*
Right lung/tibia, mg/mm 27.7  1.4 37.2  3.7*
Values are means  SE; *P  0.05 vs. sham, unpaired Student’s t-test.
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rats for three consecutive days prior to the experiments of renal
function evaluation. Throughout this period, the daily average
consumption of water (67.8  4.4 vs. 69.4  1.9 ml/kg, P 
0.05 vs. sham) and sodium (5.93  0.41 vs. 5.97  0.37
meq/kg, P  0.05 vs. sham) were similar between these two
groups of animals.
NHE3-mediated Na/H exchange in renal proximal
tubule. A major fraction of proximal tubular bicarbonate reab-
sorption is mediated by proton secretion through NHE3 (40,
52). We therefore evaluated whether the in vivo NHE3 trans-
port activity was altered in HF rats compared with sham by
measuring the rate of bicarbonate reabsorption (JHCO3) in the
native proximal tubules of these animals. To this end, station-
ary in vivo microperfusion experiments were conducted in
individual proximal convoluted tubules from HF (n  5) and
sham-operated rats (n  4). As indicated in Fig. 3A, JHCO3
was significantly increased (43  6%) in HF rats compared
with sham (2.71  0.33 vs. 1.90  0.11 nmol·cm2·s1; P 
0.05).
We next evaluated NHE3 activity by measuring the proton
dependent uptake of 22Na in renal cortical membrane vesicles
isolated from HF (n  4) and sham animals (n  4) (Fig. 3B).
In agreement with the micropuncture results, NHE3-mediated-
22Na uptake ( S3226-inhibitable 22Na uptake) was higher in
HF rats than in sham (58  3%). No significant differences
were observed between sham and HF rats in the component of
22Na uptake that was insensitive to the specific inhibitor of
NHE3 activity, S3226 (41). Taken together, these results sug-
gest that altered renal handling of sodium in HF is at least
partially attributed to enhanced NHE3-mediated sodium reab-
sorption in the renal proximal tubule.
NHE3 protein and mRNA expression in total renal cortex.
To investigate whether upregulation of NHE3 activity in HF
was associated with increases of NHE3-protein abundance
and/or mRNA levels, we carried out immunoblot and real-time
RT-PCR analyses, respectively (Fig. 4). In accordance with
results of a previous study in LAD-induced HF rats (28), we
found that NHE3 protein abundance was 68  8% higher in
renal cortex of myocardial-injured HF rats compared with
sham (Fig. 4A). Next, we determined whether the increase in
NHE3 protein amount was accompanied by similar increases in
the abundance of NHE3-mRNA in renal cortex. The data
presented in Fig. 4B reveal that NHE3-mRNA expression
relative to that of 28S ribosomal RNA was significantly higher
in HF rats than in sham (145  18%). Collectively, these
Fig. 2. LV pressure-volume relationship in sham and HF rats. Representative
pressure-volume loops in A and intraventricular pressure and dP/dt signals in
B were obtained from sham and HF rats 6 wk after LV radiofrequency ablation
or sham operation. In A, note that impaired ability of the heart to fill with blood
and then to eject it shifts the end-diastolic pressure and volume relationship
right and downward.
Table 2. Hemodynamic parameters in sham-operated and
heart failure rats measured by the Millar pressure-volume
conductance catheter system
Sham Heart Failure
No. 7 9
Heart rate, beats/min 253  15 260  11
MAP, mmHg 104  6 104  4
LVSP, mmHg 125  9 110  6
LVEDP, mmHg 4.8  0.9 23.9  2.6*
CO, ml/min 32.2  2.2 24.2  1.0*
SW, mmHg/ml 15.4  1.4 9.9  0.8*
dP/dtmax, mmHg/s 8,909  169 7,092  338*
dP/dtmax, mmHg/s 8,205  948 5,444  349*
Tau, ms 11.5  0.6 16.9  0.8*
TPR, mmHg·ml1·min1 3.2  0.2 4.4  0.2*
Values are means  SE. MAP, mean arterial pressure; LVSP, left ventric-
ular (LV) systolic pressure; LVEDP, LV end-diastolic pressure; CO, cardiac
output; SW, stroke work; dP/dtmax and dP/dtmax, maximal rate of LV
pressure increment and decrement, respectively; Tau, time constant of LV
pressure decay; TPR, total peripheral resistance. *P 0.05 vs. sham; unpaired
Student’s t-test.
Table 3. Renal function in sham-operated and heart failure
rats
Sham Heart Failure
No. 8 10
Urine output, l  min1  kg1 32.9  3.3 28.8  3.67
GFR, ml  min1  kg1 4.37  0.15 3.72  0.29
Urinary Na, mol  min1  kg1 1.90  0.44 1.27  0.16
FE Na, % 0.31  0.05 0.22  0.03
Values are means  SE. Renal function was measured in anesthetized rats
as described in MATERIALS AND METHODS. Urine output was measured gravi-
metrically. Inulin clearance was used to measure glomerular filtration rate
(GFR). Renal functional data were corrected by body weight and expressed per
kilogram body weight. FE, fractional excretion.
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findings suggest that the upregulation of proximal tubule
NHE3 activity in HF rats is, at least in part, dependent on
changes in NHE3 protein abundance and NHE3-mRNA ex-
pression levels.
Levels of NHE3 phosphorylated at the PKA consensus site
serine 552. One of the best-studied regulatory mechanisms
affecting NHE3 activity is the inhibition resulting from ago-
nists that activate cAMP-dependent protein kinase (PKA) (15,
24, 25). PKA directly phosphorylates NHE3 at serines 552 and
605, and it has been established that the residue 552 of NHE3
is phosphorylated to a much greater extent than the residue 605
at baseline in vivo (24). To determine whether altered phos-
phorylation of NHE3 may contribute to the increased activ-
ity of the exchanger in the renal proximal tubule of HF rats,
we examined the levels of phosphorylated NHE3 in renal
cortical membranes by means of immunoblotting. Experi-
ments were carried out using a phosphospecific monoclonal
antibody that recognizes NHE3 only when it is phosphory-
lated at serine 552 (24). As seen in Fig. 5, the relative ratio
of NHE3-PS552/NHE3 total was significantly lower in renal
cortical membranes isolated from HF compared with sham
rats (64  4%).
The NHE3 phosphorylation status was also evaluated within
the proximal tubule brush-border microvilli in HF and sham
rats. As seen in Fig. 6, total NHE3 expression in MMV isolated
from HF rats was higher (77  10%, P  0.001), and the
PS552-NHE3-to-NHE3 ratio was lower than in sham (60 
21%, P  0.05). These results suggest that enhanced sodium
reabsorption in the renal proximal tubule of HF rats is partially
mediated through reduced baseline PKA-dependent phosphor-
ylation of NHE3 at serine 552.
DISCUSSION
More than 50 years ago, Stead and Warren (44) noted that
the most important causes of edema in HF are salt and water
retention by the kidneys rather than the high venous pressure
caused by impaired pumping of blood out of venous system.
The potential causes of altered renal handling of salt and water
may involve a decrease in glomerular filtration rate, an increase
in tubular reabsorption of sodium, or both. In the present work,
we demonstrate that the activity of the major proximal tubule
sodium transporter NHE3 is increased in an experimental
model of myocardial injury-induced HF. Higher NHE3 activity
in the proximal tubule of HF rats is accompanied by enhanced
renal cortical NHE3 expression at both mRNA and protein
levels. In addition, the baseline PKA-dependent NHE3 phos-
phorylation at serine 552 is reduced in cortical membranes of
rats with HF.
Numerous observations underscore the crucial role of NHE3
on extracellular volume control. NHE3 is acutely and chroni-
cally regulated by the renin-angiotensin system (14, 20, 37, 49,
54), sympathetic nervous system (55), as well as by an intrare-
nal dopamine natriuretic system (22, 29, 33). Moreover, NHE3
knockout mice are hypovolemic and exhibit reduced blood
pressure (40). Furthermore, it has been previously demon-
strated by other laboratories and ours that during the prehyper-
tensive stage, NHE3 activity is increased in the renal proximal
tubule of spontaneously hypertensive rats, possibly contribut-
ing to sodium retention and volume expansion in these animals
(10, 26, 46). Here we show by both in vivo and ex vivo
approaches that proximal tubule NHE3-mediated sodium reab-
sorption is increased in HF. Upregulation of NHE3 activity is
accompanied by increases of NHE3 protein and mRNA ex-
pression. Of note, increased NHE3 protein expression have
been previously observed in other experimental models of
edematous disorders, including HF induced by ligation of the
left anterior descending coronary artery (28) and cirrhosis (18).
Despite upregulation of NHE3 function and expression, we did
not find a statistically significant change of renal sodium
handling after 6 wk of experimentally induced HF. Most likely,
the animals might have experienced a positive sodium balance
during the initial phase of heart failure and then reached a new
steady state in which renal sodium output matches sodium
intake.
NHE3 is phosphorylated on serine 552 under basal condi-
tions by the adenylyl cyclase/cAMP-activated-protein kinase A
(PKA) (24, 25) and the endogenous levels of phosphorylation
is often affected as part of acute NHE3 regulation (15, 23, 24).
Interestingly, baseline levels of NHE3 phosphorylation at this
residue may also be associated with chronic regulation of
Fig. 3. Na/H exchange (NHE3) mediated is increased in renal proximal
tubule of HF rats. NHE3 activity was measured in vivo by stationary microper-
fusion (A) and ex vivo by proton gradient-dependent sodium uptake (B). A: rate
of bicarbonate reabsorption (JHCO3) in the native proximal tubule of sham-
operated (sham, n  4) and HF rats (n  5). The number of perfused tubules
is indicated in the bars. Data are expressed as means  SE. *P  0.05 vs.
sham. B: NHE3-mediated proton-dependent uptake of 22Na into renal cortical
membrane vesicles of sham-operated and HF rats. Experiments were per-
formed in the presence or absence of the specific NHE3 inhibitor S3226 (10
M). Each assay was performed in triplicate, and the mean value of 4 animals
from each group was calculated. #P  0.001 vs. sham.
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NHE3 activity. In this regard, we have recently demonstrated
that NHE3 activity is differentially regulated before and after
development of hypertension in spontaneously hypertensive
rats and that these changes of NHE3 activity occur concur-
rently with changes of NHE3 phosphorylation status in the
spontaneously hypertensive rat model. In this work, we show
that the levels of NHE3 phosphorylation at the PKA consensus
site serine 552 in the proximal tubule apical membrane of HF
rats are lower than in sham animals. Thus, the molecular
mechanisms mediating enhanced sodium reabsorption in the
renal proximal tubule of HF rats also appear to involve post-
translational covalent modification of NHE3. Moreover, de-
creased NHE3 phosphorylation at serine 552 is associated with
an increase of NHE3 abundance in the brush-border microvilli,
supporting the notion that phosphorylation of NHE3 at this
specific PKA consensus site may play a role in subcellular
trafficking of the transporter in vivo (23, 24). In congestive HF,
volume expansion occurs in the venous side of the circulation,
while the arterial underfilling due to reduced cardiac output is
perceived as a plasma volume deficit by the arterial barorecep-
tors (7). Consequently, a series of neurohumoral adjustments is
evoked that prevents the kidney to excrete accumulated salt
and water. Among these neurohumoral responses are the acti-
vation of the renin-angiotensin-aldosterone (RAA) and the
sympathetic nervous systems.
Both ANG II and norepinephrine have been shown to
chronically increase NHE3 protein expression (42, 50, 54) and
could be involved in upregulation of transporter expression in
HF. Sonalker et al. (42) have demonstrated that chronic nor-
epinephrine infusion resulted in a significant increase of NHE3
protein abundance in the rat renal cortex. Studies by several
groups demonstrate that administration of ANG II increases
NHE3 expression at both protein and mRNA levels in rat renal
proximal tubule (14, 50) and cell culture models (34, 54).
Additionally, LAD-induced HF rats treated with ANG II re-
ceptor antagonists display normalized levels of NHE3 expres-
Fig. 4. NHE3 protein and mRNA expression are increased in
renal proximal tubule of HF rats. A, top: representative immu-
noblot of NHE3 expression in renal cortex of SHAM and HF
rats. Equivalent samples (15 g of protein for NHE3 and 5 g
for actin) of renal cortical membranes isolated from sham-
operated and HF rats were subjected to SDS-PAGE, transferred
to PVDF membranes, and analyzed by immunoblotting. Mem-
branes were incubated with monoclonal antibodies against
NHE3 (1:1,000, clone 2B9; Millipore, Temecula, CA) and actin
(1:50,000, clone JLA20; Merck, Darmstadt, Germany). Bottom:
graph of the relative protein expression levels of NHE3 in renal
cortical membranes. Values are means  SE; n  4/group,
**P  0.01 vs. sham. B, top: RT-PCR analysis of NHE3 and
28S in renal cortex of sham and HF rats. The PCR products
were analyzed by electrophoresis on agarose gel. Bottom: graph
of relative mRNA-NHE3 expression levels in renal cortical
membranes. NHE3-mRNA expression was quantified by real-
time RT-PCR. Levels of NHE3-mRNA were normalized to
those of internal control 28S ribosomal RNA (r28S-RNA).
Values are means  SE. n  5/group, **P  0.01 vs. sham.
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sion (28) and renal sodium excretion (43), suggesting that
ANG II influences renal sodium handling in cardiovascular
disease at least, in part, via NHE3.
There is evidence that coupling of ANG II to the AT1
receptor inhibits cAMP accumulation and stimulates transcel-
lular sodium transport in renal proximal tubule cells (45).
	-Adrenoceptors also stimulate proximal tubule sodium reab-
sorption; however, these receptors are coupled to Gs proteins,
which activate adenylyl cyclase to form cAMP. This paradox
was explained by Hall et al (19) who demonstrated that
	2-receptors physically interact with the sodium proton ex-
changer regulatory factor (NHERF1), a protein that is required
for PKA-mediated inhibition of NHE3. Stimulation of 	2-
adrenoceptors by its ligands sequestrates NHERF and relieves
the baseline inhibition of NHE3 by PKA. Thus, the decreased
levels of endogenous NHE3 phosphorylation observed in the
proximal tubule of HF rats might as well be mediated by
activation of the RAAS and/or the sympathetic nervous sys-
tem.
Both atrial and brain natriuretic peptides (ANP and BNP,
respectively), originating in the myocardial cells and secreting
into the plasma, play an important role in regulating extracel-
lular fluid homeostasis and blood pressure by counterbalancing
the RAAS and the sympathetic nervous system (13, 35, 53).
Plasma levels of ANP and BNP have been shown to be
increased in patients with HF and positively correlate with LV
dysfunction (6, 35, 36, 47, 56). In fact, plasma concentrations
of BNP have been widely used as a reliable prognostic indi-
cator for HF patients in all stages of the disease (32). Notably,
despite increases in the circulating levels of natriuretic pep-
tides, renal sodium retention, volume expansion, and edema
are continuously observed in patients and in experimental
animal models of HF. Indeed, resistance to the natriuretic
actions of ANP and BNP has been documented in HF subjects
(1, 9). Numerous explanations for natriuretic peptide resistance
in HF have been anticipated (7). Our results suggest that
enhanced NHE3-mediated proximal tubular sodium reabsorp-
tion diminishes sodium delivery to the distal nephron site of
natriuretic peptide action. Such decreased sodium load to the
distal nephron may attenuate the natriuretic response to these
peptides in HF patients.
Perspectives and Significance
The present study demonstrates that NHE3-mediated Na/H
exchange is significantly increased in the renal proximal tubule
of an experimental model of post-myocardial injury HF. The
molecular mechanisms underlying upregulation of NHE3 ac-
tivity in HF seem to occur at transcriptional, translational, and
posttranslational levels. These novel findings suggest that en-
hanced NHE3-mediated sodium reabsorption in the proximal
tubule may contribute to extracellular volume expansion and
ultimately to edema, one of the most important pathophysio-
logical features of HF. Moreover, our study emphasizes the
importance of undertaking a cardiorenal approach to contain
Fig. 6. NHE3 expression is increased and the relative phosphorylation ratio of
NHE3 at serine 552 is decreased in microvillus membrane vesicles (MMV)
from HF rats. Top: representative immunoblot of phosphorylated and total
NHE3 expression in MMV of sham and HF rats. Equivalent samples (15 g
of protein for NHE3 and 5 g for PS552-NHE3 and actin) of MMV isolated
from sham-operated and HF rats were prepared for immunoblot analysis. The
membranes were incubated with monoclonal antibodies against phosphory-
lated NHE3 at serine 552 [PS552-NHE3 (1:1,000)], total NHE3 (1:1,000), or
anti-actin (1:50,000). Bottom, left: graph of relative expression levels of NHE3
in MMV. Right: graph of phosphorylation ratio of NHE3 at serine 552 to total
NHE3 in MMV (PS552-NHE3/NHE3). Values are means  SE. n  4/group,
*P  0.05 and #P  0.001 vs. sham.
Fig. 5. Relative phosphorylation ratio of NHE3 at serine 552 (PS552-NHE3) is
decreased in renal cortical membranes from HF rats. Top: representative
immunoblot of phosphorylated and total NHE3 expression in renal cortex of
sham and HF rats. Equivalent samples (15 g of protein for NHE3 and 5 g
for PS552-NHE3 and actin) of renal cortical membranes isolated from sham-
operated and HF rats were subjected to SDS-PAGE, transferred to PVDF
membranes, and analyzed by immunoblotting. Membranes were incubated
with monoclonal antibodies against phosphorylated NHE3 at serine 552
(1:1,000), total NHE3 (1:1,000), or anti-actin (1:50,000). Bottom: graph of the
relative phosphorylation ratio of NHE3 at serine 552 in renal cortical mem-
branes (PS552-NHE3/NHE3). Values are means  SE. n  4/group, **P 
0.01 vs. sham.
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progression of cardiac disease. Improving the understanding of
the kidney’s adaptive and maladaptive responses to cardiac
dysfunction may lead to the development of new therapeutic
strategies.
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